Table of Contents
Orchid Pharma formerly Orchid Chemicals & Pharmaceuticals Limited, is involved in the development, manufacture and marketing of various bulk actives, formulations and nutraceuticals. Below is the details of ORCHIDPHAR Orchid Pharma Ltd Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31. Standalone Figures in The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement. Standalone Figures in A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios. Standalone Figures in Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow. Standalone Figures in Stock/Share Code -
Market Cap ₹48.49 Cr. Current Price ₹5.45 52 Week High / Low Price / Face Value ₹10 Stock P/E Book Value ₹118.72 Dividend Yield 0.00 % ROCE -7.23 % ROE -99.49 % Sales Growth (3yrs) -12.53 % Sector Pharmaceuticals Industry Pharmaceuticals - Indian - Bulk Drugs Listed on BSE AND NSE Company Website Company Website Peer Comparison in Pharmaceuticals
S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE % 1. Divi's Lab. 51.94 ₹82,900.53 Cr. 0.51 ₹492.06 Cr. 80.61 48.81 1730.47 25.19 Quarterly Results
Rs. Crores
Profit & Loss
Rs. Crores
Balance Sheet
Rs. Crores
Cash Flows
Rs. Crores
Ratios
Announcements & News
Recent Announcements
How to Invest in Mutual Funds SIP Online?